Trials / Terminated
TerminatedNCT04252703
'MInimalist' or 'MOre Complete' Strategies for Revascularization in Octogenarians
'MInimalist' or 'MOre Complete' Strategies for Revascularization in Octogenarians Presenting With Non-ST-elevation Acute Coronary Syndromes: The MIMOSA Trial
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 3 (actual)
- Sponsor
- Rigshospitalet, Denmark · Academic / Other
- Sex
- All
- Age
- 80 Years
- Healthy volunteers
- Not accepted
Summary
Older patients with co-morbidity are increasingly represented in interventional cardiology practice. They have been historically excluded from studies regarding the optimal management of NSTEACS. Though there are associated risks with invasive treatment, such patients likely derive the greatest absolute benefit from PCI. Small, though highly selective, studies suggest a routine invasive strategy may reduce the risk of recurrent myocardial infarction. The study aims to include, as far as possible, an 'all-comers' population of patients aged 80 and above to define the optimum amount of revascularization required to achieve good outcomes and satisfactory symptom relief for this challenging cohort of patients.
Conditions
- Multi Vessel Coronary Artery Disease
- Ischemic Heart Disease
- Acute Coronary Syndrome
- Heart Diseases
- Cardiovascular Diseases
- Arteriosclerosis
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Percutaneous coronary intervention (PCI) | Invasive cardiac catheterization, balloon angioplasty and intracoronary stenting. |
Timeline
- Start date
- 2020-05-13
- Primary completion
- 2022-01-01
- Completion
- 2022-01-01
- First posted
- 2020-02-05
- Last updated
- 2024-07-11
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT04252703. Inclusion in this directory is not an endorsement.